Pembrolizumab plus denosumab
ANZUP1601
Phase 2 small_molecule active
Quick answer
Pembrolizumab plus denosumab for Renal Cell Carcinoma, Clear Cell is a Phase 2 program (small_molecule) at Zealand Pharma A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Zealand Pharma A/S
- Indication
- Renal Cell Carcinoma, Clear Cell
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active